Thomas Edward Hamilton

Insider Reports History

Entity
Individual
Location
211 Stuyvesant Ave, Rye, NY
Signature
/s/ Anthony C. Green, as Attorney-in-Fact for Thomas Edward Hamilton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Edward Hamilton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Larimar Therapeutics, Inc. Director Common Stock 565K $4.94M $8.74 Feb 16, 2024 Direct
ANNALY CAPITAL MANAGEMENT INC Director Common Stock 82.5K $1.56M $18.88 May 15, 2024 Cure FA Foundation, Inc.
Larimar Therapeutics, Inc. Director Common Stock 159K $1.39M $8.74 Feb 16, 2024 Post Edison, LLC
ANNALY CAPITAL MANAGEMENT INC Director Common Stock 32.5K $614K $18.88 May 15, 2024 Direct
ANNALY CAPITAL MANAGEMENT INC Director Deferred Stock Units 36.3K May 15, 2024 Direct
Larimar Therapeutics, Inc. Director Stock Option (Right to Buy) 19K May 29, 2024 Direct

Insider Reports Filed by Thomas Edward Hamilton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLY ANNALY CAPITAL MANAGEMENT INC May 15, 2024 1 $0 4 May 17, 2024 Director
LRMR Larimar Therapeutics, Inc. Feb 16, 2024 2 $500K 4 May 31, 2024 Director
NLY ANNALY CAPITAL MANAGEMENT INC May 17, 2023 1 $0 4 May 19, 2023 Director
LRMR Larimar Therapeutics, Inc. May 9, 2023 1 $0 4 May 11, 2023 Director
LRMR Larimar Therapeutics, Inc. Sep 16, 2022 1 $1M 4 Sep 20, 2022 Director
NLY ANNALY CAPITAL MANAGEMENT INC May 18, 2022 1 $0 4 May 20, 2022 Director
LRMR Larimar Therapeutics, Inc. May 10, 2022 1 $0 4 May 12, 2022 Director
LRMR Larimar Therapeutics, Inc. Jun 30, 2021 1 $496K 4 Jul 2, 2021 Director
NLY ANNALY CAPITAL MANAGEMENT INC May 19, 2021 1 $0 4 May 21, 2021 Director
LRMR Larimar Therapeutics, Inc. May 12, 2021 1 $0 4 May 17, 2021 Director